Systemic sclerosis (scleroderma): open trials in Austria

• NCT06195072

  A study of different investigational treatments in people with the interstitial lung disease that accompanies scleroderma (CONQUEST)

  Trial Treatment · Phase 2 · Scleroderma Research Foundation

  Johannes Kepler University Linz, Linz · Ordensklinikum Linz GmbH, Linz

  Registry updated 2026-10-08

• NCT06470048

  A randomized, double-blind, parallel group, placebo-controlled multicenter study to evaluate efficacy, safety and tolerability of ianalumab in participants with diffuse cutaneous systemic sclerosis

  Trial Treatment · Phase 2 · Novartis Pharma AG

  Medical University of Graz, Graz

  Registry updated 2026-10-06

All Systemic sclerosis (scleroderma) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error